The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGb Group Regulatory News (GBG)

Share Price Information for Gb Group (GBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 319.00
Bid: 318.60
Ask: 319.00
Change: 5.80 (1.85%)
Spread: 0.40 (0.126%)
Open: 320.00
High: 320.20
Low: 309.60
Prev. Close: 313.20
GBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in CredoLab Pte Ltd

20 Aug 2020 07:00

RNS Number : 6203W
GB Group PLC
20 August 2020
 

 

 

 

Embargoed until 7.00 a.m.

Thursday, 20th August 2020

 

 

GB GROUP PLC

("GBG", "Group" or the "Company")

 

Investment in CredoLab Pte. Ltd ("CredoLab")

 

GB Group (AIM: GBG), the identity data intelligence specialist, is leading the US$7.0 million first close of a Series A investment into CredoLab, a developer of bank-grade digital scorecards headquartered in Singapore.

 

In an all-share transaction, GBG will purchase a minority stake in CredoLab for a total consideration of US$3.0 million. This is in accordance with GBG's ongoing cash management strategy.

 

Established in 2016, CredoLab develops Artificial Intelligence driven bank grade digital scorecards for businesses that need to assess an applicant's risk profile and make better credit decisions. A closer collaboration with CredoLab will enhance GBG's digital on-boarding solution and allow the Company to reach new fintech and neobank market segments.

 

Consideration

In exchange for GBG's minority stake in CredoLab, GBG will issue to CredoLab 321,882 Ordinary Shares of 2.5 pence each in GBG (the "Consideration Shares").

 

Application has been made to the London Stock Exchange for the Consideration Shares to be admitted to trading on the AIM. It is expected that admission to the AIM will become effective and that dealings on the AIM will commence in the Consideration Shares on Friday, 21st August 2020.

 

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the Consideration Shares, its issued share capital will comprise 195,024,387 Ordinary Shares.

 

There are no shares held in treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the Disclosure and Transparency Rules.

 

Chris Clark, CEO, commented:

"GBG's fraud and compliance solution allows financial institutions to onboard and transact with their customers quickly, safely, and securely. We have experienced first-hand CredoLab's capabilities from our ongoing commercial partnership. The company's AI-based proprietary technology will not only complement our existing offering but also provide critical behavioural risk reference data from good customers who are financially excluded."

 

Peter Barcak, CEO and Co-Founder of CredoLab, said:

"Banks and lenders always grapple with finding data that allows them to assess customers' affordability and overall creditworthiness. While GBG's fraud solution flags suspicious loan and credit card applicants during the onboarding journey, CredoLab's behavioural risk score and algorithm lowers false positives and false negatives on delinquent behaviours to discern the probability of a customer to repay. CredoLab will use the funds to consolidate its leadership in Southeast Asia and expand its presence in key markets across Asia, Latin America, Europe, and Africa."

 

For further information, please contact:

 

GB Group plc

Chris Clark, Chief ExecutiveDave Wilson, Group Finance and Operations Director

 

+44 (0)1244 657333

Peel Hunt LLP (Nominated Adviser and Broker)Edward Knight

Nick Prowting

Ed Allsopp

 

 

+44 (0)20 7418 8900

Tulchan Communications (Public Relations)

Matt Low

Deborah Rooney

+44 (0)20 7353 4200

 

Website

www.gbgplc.com

 

About GBG

 

GBG offers a range of solutions that help organisations quickly validate and verify the identity and location of their customers.

 

Our market-leading technology, data and expertise help our customers improve digital access, deliver a seamless experience and establish trust so that they can transact quickly, safely and securely with their customers online. 

 

Headquartered in the UK and with over 1,000 team members across 16 countries, we work with 20,000 customers in over 70 countries. Some of the world's best-known businesses rely on GBG to provide digital services and keep the economy moving, from US e-commerce giants to Asia's biggest banks and European household brands.

 

To find out more about how we help our customers establish trust with their customers, visit www.gbgplc.com and follow us on LinkedIn and Twitter @gbgplc.

 

About CredoLab

 

Established in Singapore in 2016, CredoLab develops bank grade digital scorecards for banks, lenders, e-commerce, travel, ride-hailing, e-wallets, insurance, retail companies and any business that needs to make better credit decisions. CredoLab uses only privacy-consented and permissioned smartphone and web behavioural data to help its clients expand market share while keeping the cost of risk under control.

 

Its AI-based algorithm processes 3.8 million features to find predictive micro-behavioural patterns before converting them into risk scores. These scores enable any lender to assess the creditworthiness of their applicants even in the absence of credit bureau data. To date, CredoLab has enabled the issuance of US$2.0 billion in loans across 20 countries and has maintained its predictive power even in the presence of payment holidays.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQKKCBDQBKDBFD
Date   Source Headline
30th Apr 20243:00 pmRNSTotal Voting Rights
29th Apr 20247:00 amRNSDirectorate Change
26th Apr 20242:33 pmRNSHolding(s) in Company
23rd Apr 20247:00 amRNSFY24 trading update
28th Mar 202412:47 pmRNSTotal Voting Rights
29th Feb 20243:44 pmRNSTotal Voting Rights
31st Jan 20244:59 pmRNSDirector/PDMR Shareholding
31st Jan 20241:00 pmRNSTotal Voting Rights
30th Jan 20247:00 amRNSDirectorate change and in-line trading update
26th Jan 20248:30 amRNSHolding(s) in Company
19th Jan 202410:01 amRNSBlock listing Interim Review
29th Dec 202311:54 amRNSTotal Voting Rights
19th Dec 20238:50 amRNSHolding(s) in Company
4th Dec 20231:49 pmRNSDirector/PDMR Shareholding
30th Nov 20232:12 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
31st Oct 20233:15 pmRNSTotal Voting Rights
23rd Oct 20232:12 pmRNSHolding(s) in Company
19th Oct 20237:00 amRNSHalf-year trading update
29th Sep 20237:00 amRNSTotal Voting Rights
31st Aug 20232:03 pmRNSTotal Voting Rights - Correction
31st Aug 20237:00 amRNSTotal Voting Rights
10th Aug 20234:47 pmRNSPDMR shareholding, Issue of Ordinary Shares & TVR
31st Jul 20237:00 amRNSTotal Voting Rights
20th Jul 202312:26 pmRNSResult of AGM
20th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSBlock listing Interim Review
14th Jul 20232:13 pmRNSDirector/PDMR Shareholding
30th Jun 20237:00 amRNSTotal Voting Rights
26th Jun 20235:24 pmRNSPosting of Annual Report and Notice of AGM
15th Jun 20237:00 amRNSFinal Results
31st May 20237:00 amRNSTotal Voting Rights
2nd May 20232:01 pmRNSTotal Voting Rights
24th Apr 20237:00 amRNSDirector Dealing
20th Apr 20237:00 amRNSPre-close trading update
6th Apr 20233:01 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202312:59 pmRNSHolding(s) in Company
24th Mar 20238:58 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSDirector Retirement
28th Feb 20237:00 amRNSTotal Voting Rights
22nd Feb 20237:00 amRNSDirector Dealing
21st Feb 20237:00 amRNSTrading update
7th Feb 20237:00 amRNSBlock listing Interim Review
31st Jan 20237:00 amRNSTotal Voting Rights
24th Jan 20233:30 pmRNSHolding(s) in Company
19th Jan 20237:00 amRNSCapital Markets Event
29th Nov 20227:00 amRNSHalf-year Report
11th Nov 20228:42 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.